2021
DOI: 10.2147/idr.s303739
|View full text |Cite
|
Sign up to set email alerts
|

Epidemiological Characterization of Colistin and Carbapenem Resistant Enterobacteriaceae in a Tertiary: A Hospital from Anhui Province

Abstract: Purpose Antimicrobial resistance, especially carbapenem resistance Enterobacteriaceae and plasmid mediated mobile colistin resistance, is a serious issue worldwide. This study was designed to determine the epidemiological characteristics of plasmid mediated colistin resistance and carbapenem resistant Enterobacteriaceae from tertiary A hospital located in Hefei, China. Methods Totally, 158 carbapenems resistant Enterobacteriaceae (CRE) were screened for antibiotic susce… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
6
0
1

Year Published

2021
2021
2024
2024

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 12 publications
(9 citation statements)
references
References 61 publications
(64 reference statements)
0
6
0
1
Order By: Relevance
“…This trend was also found by Hashemi et al [ 48 ], with an Enterobacteriaceae resistance rate to imipenem of around 19%. Carbapenems, therefore, remain, to this day, the most active molecules against uropathogenic Enterobacteriaceae [ 49 ].…”
Section: Discussionmentioning
confidence: 99%
“…This trend was also found by Hashemi et al [ 48 ], with an Enterobacteriaceae resistance rate to imipenem of around 19%. Carbapenems, therefore, remain, to this day, the most active molecules against uropathogenic Enterobacteriaceae [ 49 ].…”
Section: Discussionmentioning
confidence: 99%
“…Conjugal transfer experiments were carried out by using the filter mating method with rifampicin-resistant, plasmid-free strain Escherichia coli 600 as the recipient ( Hameed et al, 2021 ), and K. pneumoniae strain DY1928 as the donor. Transconjugants were selected on agar medium (OXOID, Hampshire, UK) supplemented with meropenem (2 μg/ml) and rifampicin (200 μg/ml).…”
Section: Methodsmentioning
confidence: 99%
“…The worldwide surveillance carried out by the World Health Organization (WHO) described antimicrobial resistance in several parts of the world [5]. Many cases have reported bacterial resistance to the last therapeutic options to combat infectious diseases such as colistin resistance that has been reported in different parts of the world [6,7].…”
Section: Introductionmentioning
confidence: 99%